5 Likes KarlT February 20, 2023, 7:58am #7 I think the concern is that the percent of muscle loss is considerably higher when using this drug
Start with documentation review
Triple-Hormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial (NEJM 2023)PubMed 2023 TRIUMPH-1: Phase 3 study of LY3437943 in adults with obesityClinicalTrials.gov 2024 Retatrutide is an investigational drug currently in Phase 3 clinical trials
This paper attempts to explain, from a food science perspective, the mechanisms by which erythritol and xylitol affect these hormones and discusses their potential implications for appetite regulation and metabolic health
Whether Im looking for an immune boost, detoxification, or enhanced hydration, I trust Formula Wellness in Dallas to deliver the best results every time
Wang G, Gao S, Su N, Xu J, Fu D